Cancer screenings, diagnostic technology evolution, and cancer control
- PMID:19109777
- DOI: 10.1007/978-1-59745-416-2_6
Cancer screenings, diagnostic technology evolution, and cancer control
Abstract
Screening should allow for the anticipation of cancer diagnosis at an earlier stage, when curative treatment is possible. Screening for cervical, large bowel, and breast cancer were shown to be effective in reducing mortality. The wide acceptance of the screening concept led to the wide diffusion also of screening of uncertain benefit against prostate cancer and skin melanoma. Diagnostic technologies are continuously evolving, and new tests are proposed to improve existing screenings or as screening tests for additional cancer sites (e.g., lung cancer). Cancer screening, however, is a complex and costly intervention that does not result only in benefits but also may cause harm. A major emerging problem of screening is overdiagnosis, or the detection of cases that would have not progressed to the symptomatic phase in the absence of screening. Thus, both experimental and observational evaluation studies are needed to reduce harm caused by screenings and to select effective interventions among many proposed innovations. Finally, the research of markers to assess the aggressive nature of screen-detected lesions is of great importance to improve screenings ' harm/benefit ratio.
Similar articles
- Comparison of observed and expected numbers of detected cancers in the research center for cancer prevention and screening program.Hamashima C, Sobue T, Muramatsu Y, Saito H, Moriyama N, Kakizoe T.Hamashima C, et al.Jpn J Clin Oncol. 2006 May;36(5):301-8. doi: 10.1093/jjco/hyl022. Epub 2006 May 30.Jpn J Clin Oncol. 2006.PMID:16735372
- [Screening and early diagnosis of cancers: 2 ways for a same goal].Bourmaud A, Nourissat A, Chauvin F.Bourmaud A, et al.Rev Prat. 2010 Feb 20;60(2):183-8, 190.Rev Prat. 2010.PMID:20225552French.
- The case for early detection.Etzioni R, Urban N, Ramsey S, McIntosh M, Schwartz S, Reid B, Radich J, Anderson G, Hartwell L.Etzioni R, et al.Nat Rev Cancer. 2003 Apr;3(4):243-52. doi: 10.1038/nrc1041.Nat Rev Cancer. 2003.PMID:12671663Review.
- Ethical issues for cancer screenings. Five countries--four types of cancer.Ustun C, Ceber E.Ustun C, et al.Prev Med. 2004 Aug;39(2):223-9. doi: 10.1016/j.ypmed.2004.03.020.Prev Med. 2004.PMID:15226029
- Screening for cancer: evaluating the evidence.Gates TJ.Gates TJ.Am Fam Physician. 2001 Feb 1;63(3):513-22.Am Fam Physician. 2001.PMID:11272300Review.
Cited by
- Cryosurgery for lung cancer.Niu L, Xu K, Mu F.Niu L, et al.J Thorac Dis. 2012 Aug;4(4):408-19. doi: 10.3978/j.issn.2072-1439.2012.07.13.J Thorac Dis. 2012.PMID:22934144Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources